[ad_1]
DexCom Inc., a maker of monitoring devices for diabetes patients, cut its full-year sales outlook on Thursday — a move that surprised some analysts and investors and sent its stock tumbling after hours — as the company deals with a shortfall in new patients and weaker trends abroad.
[ad_2]
Source link
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...
Investors will measure the response to this week's selloff, which came at a time when markets are entering a strong...
Tesla CEO and X owner Elon Musk gestures behind protective glass during a rally for Republican presidential nominee and former...
Sam Altman Co-founder and CEO of OpenAI speaks during the Italian Tech Week 2024 at OGR Officine Grandi Riparazioni on...
A lone traveler makes his way past a nearly deserted TSA security screening area at Orlando International Airport ahead of...
© AlertsPicks.com
